EGFR and neoplasm: In this context, recent reports including a substantial percentage of patients with an initially negative test for EGFR exon 20 p.T790M detection will become positive at subsequent testing [15,16], probably due to higher tumor burden or increased tumor shedding capacity, confirmed the concept that repeating a liquid biopsy test might increase its overall sensitivity providing information potentially useful for clinical decision making.